Anlon Healthcare Limited (NSE:AHCL)

India flag India · Delayed Price · Currency is INR
111.06
+2.74 (2.53%)
At close: Mar 5, 2026
Market Cap6.20B
Revenue (ttm)1.70B +155.3%
Net Income346.64M +258.9%
EPS7.84 +17.4%
Shares Out53.15M
PE Ratio14.87
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume268,930
Average Volume147,104
Open109.00
Previous Close108.32
Day's Range107.92 - 111.65
52-Week Range90.78 - 172.75
Betan/a
RSI46.32
Earnings DateFeb 9, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumat... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 2013
Employees 117
Stock Exchange National Stock Exchange of India
Ticker Symbol AHCL
Full Company Profile

Financial Performance

In fiscal year 2025, Anlon Healthcare's revenue was 1.20 billion, an increase of 80.64% compared to the previous year's 666.16 million. Earnings were 205.18 million, an increase of 112.46%.

Financial Statements